美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Lunai Bioworks

0.4015

+0.036510.00%

成交量：132.76万

成交额：49.54万

市值：971.12万

市盈率：-0.05

高：0.4015

开：0.3791

低：0.3527

收：0.3650

52周最高：7.29

52周最低：0.1513

股本：2,418.74万

流通股本：1,470.58万

量比：0.06

换手率：9.03%

股息：- -

股息率：- -

每股收益(TTM):-7.5469

每股收益(LYR):-10.7843

净资产收益率：-366.44%

总资产收益率：-13.32%

市净率：-0.72

市盈率(LYR):-0.04

数据加载中...

总览公司新闻资讯公告

Lunai Bioworks Inc.盘中异动急速下跌5.05%报0.209美元

Lunai Bioworks公司CEO与CFO自愿同意在休假期间暂缓领取薪酬——SEC文件披露

Lunai Bioworks公司于2026年2月27日在美国和加拿大实施员工临时休假措施 - 美国证券交易委员会文件披露

Lunai Bioworks Inc.盘中异动快速下跌5.00%

Lunai Bioworks Inc.盘中异动股价大跌8.78%报0.670美元

Lunai Bioworks (纳斯达克: LNAI) 携手临床阶段合作伙伴启动AI肿瘤学试点项目，分析转移性结直肠癌生存期随机II期试验数据

Lunai Bioworks Inc.盘中异动快速拉升5.08%报0.900美元

Lunai Bioworks Inc.盘中异动股价大涨6.02%

Lunai Bioworks获得首份许可意向书，标志着在类人癌症模型中实现完全肿瘤退化的重大突破

Lunai Bioworks Inc.盘中异动早盘快速拉升5.24%

Lunai Bioworks Inc.盘中异动大幅拉升5.83%报1.090美元

Lunai Bioworks在临床前人源化模型中实现原发性和转移性胰腺肿瘤的完全消退，标志着异体癌症免疫疗法的突破

Lunai Bioworks Inc.盘中异动早盘股价大跌5.83%报0.970美元

Lunai Bioworks实现同种异体癌症免疫疗法的重大突破

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/LNAI/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LNAI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LNAI\",,,,,undefined,":{"symbol":"LNAI","market":"US","secType":"STK","nameCN":"Lunai Bioworks","latestPrice":0.4015,"timestamp":1774468800000,"preClose":0.365,"halted":0,"volume":1327626,"delay":0,"changeRate":0.10000000000000009,"floatShares":14705800,"shares":24187399,"eps":-7.5469,"marketStatus":"盘前交易","change":0.0365,"latestTime":"03-26 04:11:21 EDT","open":0.3791,"high":0.4015,"low":0.3527,"amount":495443.6698239,"amplitude":0.133699,"askPrice":0.4,"askSize":8,"bidPrice":0.371,"bidSize":60,"shortable":3,"etf":0,"ttmEps":-7.5469,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774531800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.4015,"postHourTrading":{"tag":"盘后","latestPrice":0.386,"preClose":0.4015,"latestTime":"19:42 EDT","volume":39570,"amount":15183.651823,"timestamp":1774482172686,"change":-0.0155,"changeRate":-0.038605,"amplitude":0.090411},"volumeRatio":0.06150595505470411,"impliedVol":1.4337,"impliedVolPercentile":0.8067},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LNAI\",,,,,undefined,":{"symbol":"LNAI","floatShares":14705800,"roa":"-13.32%","roe":"-366.44%","lyrEps":-10.784282,"volumeRatio":0.06150595505470411,"shares":24187399,"dividePrice":0,"high":0.4015,"amplitude":0.133699,"preClose":0.365,"low":0.3527,"week52Low":0.1513,"pbRate":"-0.72","week52High":7.29,"institutionHeld":0,"latestPrice":0.4015,"committee":0.764706,"eps":-7.5469,"divideRate":0,"volume":1327626,"delay":0,"ttmEps":-7.5469,"open":0.3791,"prevYearClose":0.8817,"prevWeekClose":0.4685,"prevMonthClose":0.3705,"prevQuarterClose":0.8817,"fiveDayClose":0.4019,"twentyDayClose":0.4254,"sixtyDayClose":0.9709},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LNAI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-17","symbol":"LNAI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1771304400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2025-11-14","symbol":"LNAI","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":0.13},{"market":"US","date":"2025-09-30","symbol":"LNAI","defaultRemindTime":1759239000000,"type":"split","dateTimestamp":1759204800000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2025-09-29","symbol":"LNAI","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1759118400000,"reportTimeType":"","actualEps":-0.76},{"market":"US","date":"2025-05-15","symbol":"LNAI","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":0}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LNAI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LNAI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LNAI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LNAI","date":"2026-03-24","current":-0.053201,"percent":0.872881,"low":-0.265446,"twenty":-0.177297,"median":-0.152344,"eighty":-0.112135,"high":-0.035532,"avg":-0.146294,"sd":0.049702,"marketCap":9928909},"quantilePoints":[{"date":"2025-10-03","current":-0.160171,"twenty":-0.164877,"median":-0.163112,"eighty":-0.161348,"marketCap":28511703},{"date":"2025-10-10","current":-0.161474,"twenty":-0.165919,"median":-0.164078,"eighty":-0.161474,"marketCap":28743506},{"date":"2025-10-17","current":-0.158869,"twenty":-0.16512,"median":-0.161474,"eighty":-0.158869,"marketCap":28279901},{"date":"2025-10-24","current":-0.135429,"twenty":-0.16512,"median":-0.160171,"eighty":-0.152098,"marketCap":24107456},{"date":"2025-10-31","current":-0.122514,"twenty":-0.163557,"median":-0.158218,"eighty":-0.135687,"marketCap":21808324},{"date":"2025-11-07","current":-0.132813,"twenty":-0.161474,"median":-0.152344,"eighty":-0.130739,"marketCap":23641716},{"date":"2025-11-14","current":-0.134115,"twenty":-0.161474,"median":-0.143888,"eighty":-0.121701,"marketCap":23873497},{"date":"2025-11-21","current":-0.254829,"twenty":-0.163557,"median":-0.147149,"eighty":-0.123011,"marketCap":33376540},{"date":"2025-11-28","current":-0.211108,"twenty":-0.166054,"median":-0.152344,"eighty":-0.125001,"marketCap":27650221},{"date":"2025-12-05","current":-0.232577,"twenty":-0.211108,"median":-0.158218,"eighty":-0.130221,"marketCap":30462108},{"date":"2025-12-12","current":-0.20753,"twenty":-0.221843,"median":-0.160171,"eighty":-0.132813,"marketCap":27181573},{"date":"2025-12-19","current":-0.184259,"twenty":-0.212897,"median":-0.161474,"eighty":-0.134115,"marketCap":24133572},{"date":"2025-12-26","current":-0.176388,"twenty":-0.211466,"median":-0.164729,"eighty":-0.134115,"marketCap":23102623},{"date":"2026-01-02","current":-0.157729,"twenty":-0.211108,"median":-0.164729,"eighty":-0.134896,"marketCap":20658806},{"date":"2026-01-09","current":-0.162828,"twenty":-0.208961,"median":-0.16538,"eighty":-0.135424,"marketCap":21326580},{"date":"2026-01-16","current":-0.16442,"twenty":-0.206179,"median":-0.165717,"eighty":-0.136203,"marketCap":21535113},{"date":"2026-01-23","current":-0.164223,"twenty":-0.200455,"median":-0.16538,"eighty":-0.13724,"marketCap":21509339},{"date":"2026-01-30","current":-0.150287,"twenty":-0.192502,"median":-0.16442,"eighty":-0.139063,"marketCap":19684091},{"date":"2026-02-06","current":-0.115725,"twenty":-0.190708,"median":-0.163453,"eighty":-0.135462,"marketCap":15157289},{"date":"2026-02-13","current":-0.146316,"twenty":-0.189626,"median":-0.161474,"eighty":-0.135462,"marketCap":19163931},{"date":"2026-02-20","current":-0.111222,"twenty":-0.189268,"median":-0.161474,"eighty":-0.134115,"marketCap":13960941},{"date":"2026-02-27","current":-0.077077,"twenty":-0.187121,"median":-0.158869,"eighty":-0.128849,"marketCap":9674942},{"date":"2026-03-06","current":-0.069658,"twenty":-0.184259,"median":-0.157729,"eighty":-0.122516,"marketCap":8743729},{"date":"2026-03-13","current":-0.037035,"twenty":-0.183139,"median":-0.156666,"eighty":-0.116398,"marketCap":4648809},{"date":"2026-03-20","current":-0.074186,"twenty":-0.178206,"median":-0.153221,"eighty":-0.113305,"marketCap":9312132},{"date":"2026-03-24","current":-0.0791,"twenty":-0.177297,"median":-0.152344,"eighty":-0.112135,"marketCap":9928909}],"updateTime":1774512681105},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LNAI\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618696959","title":"Lunai Bioworks Inc.盘中异动 急速下跌5.05%报0.209美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618696959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618696959?lang=zh_cn&edition=fundamental","pubTime":"2026-03-11 01:28","pubTimestamp":1773163718,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日01时28分，Lunai Bioworks Inc.股票出现异动，股价快速下挫5.05%。截至发稿，该股报0.209美元/股，成交量29.0909万股，换手率1.20%，振幅9.09%。Lunai Bioworks Inc.股票所在的生物技术行业中，整体涨幅为1.97%。其相关个股中，Longeveron Inc.、Cingulate Inc C/Wts 10/12/2026 、Acurx Pharmaceuticals, Inc.涨幅较大，Longeveron Inc.、Acurx Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.较为活跃，换手率分别为1066.36%、983.18%、694.08%，振幅较大的相关个股有Longeveron Inc.、Cingulate Inc C/Wts 10/12/2026 、Acurx Pharmaceuticals, Inc.，振幅分别为109.01%、60.16%、46.54%。Lunai Bioworks Inc.公司简介：Lunai Bioworks Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031101283895474c92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031101283895474c92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RENB","BK4139","LNAI"],"gpt_icon":1},{"id":"1175041179","title":"Lunai Bioworks公司CEO与CFO自愿同意在休假期间暂缓领取薪酬——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1175041179","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175041179?lang=zh_cn&edition=fundamental","pubTime":"2026-03-06 05:50","pubTimestamp":1772747457,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会（SEC）的文件显示，Lunai Bioworks公司首席执行官与首席财务官已主动达成一致，将在公司实施强制休假措施期间，自愿暂缓领取其个人薪酬。\n这一决定体现了管理层在当前特殊时期与公司共渡难关的坚定承诺。通过暂时推迟薪资支付，公司有望在业务调整期间优化现金流管理，为后续运营恢复保留更多财务灵活性。\n","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LNAI"],"gpt_icon":0},{"id":"1191374910","title":"Lunai Bioworks公司于2026年2月27日在美国和加拿大实施员工临时休假措施 - 美国证券交易委员会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1191374910","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191374910?lang=zh_cn&edition=fundamental","pubTime":"2026-03-06 05:48","pubTimestamp":1772747306,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会的文件，Lunai Bioworks公司已决定自2026年2月27日起，对其在美国和加拿大业务的员工实施临时休假措施。此举标志着公司运营策略的调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"gpt_icon":0},{"id":"2614970548","title":"Lunai Bioworks Inc.盘中异动 快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614970548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614970548?lang=zh_cn&edition=fundamental","pubTime":"2026-02-28 04:56","pubTimestamp":1772225778,"startTime":"0","endTime":"0","summary":"北京时间2026年02月28日04时56分，Lunai Bioworks Inc.股票出现波动，股价急速跳水5.00%。截至发稿，该股报0.380美元/股，成交量25.7378万股，换手率1.06%，振幅4.85%。Lunai Bioworks Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Ensysce Biosciences, Inc.、Edesa Biotech, Inc.、Cardio Diagnostics Holdings Inc.涨幅较大，Ensysce Biosciences, Inc.、Cardio Diagnostics Holdings Inc.、Edesa Biotech, Inc.较为活跃，换手率分别为7585.73%、1007.93%、488.05%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Edesa Biotech, Inc.、Ensysce Biosciences, Inc.，振幅分别为82.34%、69.03%、51.85%。Lunai Bioworks Inc.公司简介：Lunai Bioworks Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022804561995424e92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022804561995424e92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LNAI","BK4139","RENB"],"gpt_icon":0},{"id":"2612999704","title":"Lunai Bioworks Inc.盘中异动 股价大跌8.78%报0.670美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612999704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612999704?lang=zh_cn&edition=fundamental","pubTime":"2026-02-17 22:43","pubTimestamp":1771339409,"startTime":"0","endTime":"0","summary":"北京时间2026年02月17日22时43分，Lunai Bioworks Inc.股票出现异动，股价急速跳水8.78%。截至发稿，该股报0.670美元/股，成交量10.9569万股，换手率0.47%，振幅3.95%。Lunai Bioworks Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Polaryx Therapeutics, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 、Biovie Inc C/Wts 08/08/2030涨幅较大，Ernexa Therapeutics Inc.、Quince Therapeutics, Inc.、Moolec Science Sa较为活跃，换手率分别为67.17%、36.32%、33.27%，振幅较大的相关个股有Polaryx Therapeutics, Inc.、Xtl生物制药、Eyepoint, Inc.，振幅分别为23.24%、18.82%、18.62%。Lunai Bioworks Inc.公司简介：Lunai Bioworks Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021722432997a6671d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021722432997a6671d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RENB","BK4139","LNAI"],"gpt_icon":0},{"id":"1171837745","title":"Lunai Bioworks (纳斯达克: LNAI) 携手临床阶段合作伙伴启动AI肿瘤学试点项目，分析转移性结直肠癌生存期随机II期试验数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1171837745","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171837745?lang=zh_cn&edition=fundamental","pubTime":"2026-02-09 22:18","pubTimestamp":1770646723,"startTime":"0","endTime":"0","summary":"Lunai Bioworks (纳斯达克: LNAI) 近日宣布，与一家临床阶段的合作伙伴共同启动了一项人工智能肿瘤学试点项目。该项目的核心任务是利用先进的人工智能技术，对一项针对转移性结直肠癌患者的随机II期生存期临床试验数据进行深度分析。此举旨在探索AI在加速肿瘤学研究与药物开发方面的巨大潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"gpt_icon":0},{"id":"2606730216","title":"Lunai Bioworks Inc.盘中异动 快速拉升5.08%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606730216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606730216?lang=zh_cn&edition=fundamental","pubTime":"2026-01-27 23:50","pubTimestamp":1769529013,"startTime":"0","endTime":"0","summary":"北京时间2026年01月27日23时50分，Lunai Bioworks Inc.股票出现波动，股价快速上涨5.08%。截至发稿，该股报0.900美元/股，成交量21.2002万股，换手率0.90%，振幅9.33%。Lunai Bioworks Inc.股票所在的生物技术行业中，整体涨幅为1.53%。其相关个股中，Biomx Inc.、Briacell Therapeutics Corp C/Wts 、Lisata Therapeutics, Inc.涨幅较大，Biomx Inc.、Vyome Holdings, Inc.、Genenta Science Spa较为活跃，换手率分别为1543.34%、736.96%、227.46%，振幅较大的相关个股有Biomx Inc.、Vyome Holdings, Inc.、Novabay Pharmaceuticals, Inc.，振幅分别为53.90%、39.87%、36.19%。Lunai Bioworks Inc.公司简介：Lunai Bioworks Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127235013a6b3b484&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127235013a6b3b484&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LNAI","RENB","BK4139"],"gpt_icon":0},{"id":"2594233094","title":"Lunai Bioworks Inc.盘中异动 股价大涨6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594233094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594233094?lang=zh_cn&edition=fundamental","pubTime":"2025-12-24 22:54","pubTimestamp":1766588048,"startTime":"0","endTime":"0","summary":"北京时间2025年12月24日22时54分，Lunai Bioworks Inc.股票出现异动，股价急速拉升6.02%。截至发稿，该股报1.052美元/股，成交量2887股，换手率0.01%，振幅1.08%。Lunai Bioworks Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Indaptus Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts 、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Dermata Therapeutics, Inc.、Indaptus Therapeutics, Inc.、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为1691.95%、1009.79%、35.50%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Citius Pharmaceuticals, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为51.00%、35.58%、20.00%。Lunai Bioworks Inc.公司简介：Lunai Bioworks Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224225409953b9d5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224225409953b9d5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RENB","LNAI"],"gpt_icon":1},{"id":"1158338920","title":"Lunai Bioworks获得首份许可意向书，标志着在类人癌症模型中实现完全肿瘤退化的重大突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1158338920","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158338920?lang=zh_cn&edition=fundamental","pubTime":"2025-11-25 20:46","pubTimestamp":1764074773,"startTime":"0","endTime":"0","summary":"Lunai Bioworks获得首份许可意向书，标志着在类人癌症模型中实现完全肿瘤退化的重大突破","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LNAI"],"gpt_icon":0},{"id":"2586440790","title":"Lunai Bioworks Inc.盘中异动 早盘快速拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586440790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586440790?lang=zh_cn&edition=fundamental","pubTime":"2025-11-24 23:21","pubTimestamp":1763997661,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日23时21分，Lunai Bioworks Inc.股票出现波动，股价快速拉升5.24%。截至发稿，该股报1.31美元/股，成交量2.6719万股，换手率0.11%，振幅6.66%。Lunai Bioworks Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Enlivex Therapeutics Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Enlivex Therapeutics Ltd.、Pasithea Therapeutics Corp.、Osr Holdings, Inc.较为活跃，换手率分别为633.82%、457.55%、69.59%，振幅较大的相关个股有Enlivex Therapeutics Ltd.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Pasithea Therapeutics Corp.，振幅分别为47.95%、42.12%、39.27%。Lunai Bioworks Inc.公司简介：Lunai Bioworks Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242321029517b73e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242321029517b73e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LNAI","RENB","BK4139"],"gpt_icon":0},{"id":"2584599028","title":"Lunai Bioworks Inc.盘中异动 大幅拉升5.83%报1.090美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584599028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584599028?lang=zh_cn&edition=fundamental","pubTime":"2025-11-18 23:31","pubTimestamp":1763479868,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日23时31分，Lunai Bioworks Inc.股票出现波动，股价大幅上涨5.83%。截至发稿，该股报1.090美元/股，成交量3.1332万股，换手率0.14%，振幅9.71%。Lunai Bioworks Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Olema Pharmaceuticals, Inc.、Can Fite Biopharma Ltd、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Can Fite Biopharma Ltd、Clearmind Medicine Inc.、Galmed Pharmaceuticals Ltd.较为活跃，换手率分别为1740.14%、1017.54%、339.02%，振幅较大的相关个股有Olema Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Can Fite Biopharma Ltd，振幅分别为106.34%、49.55%、44.48%。Lunai Bioworks Inc.公司简介：Lunai Bioworks Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118233108950c7a39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118233108950c7a39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LNAI","BK4139","RENB"],"gpt_icon":0},{"id":"1197356752","title":"Lunai Bioworks在临床前人源化模型中实现原发性和转移性胰腺肿瘤的完全消退，标志着异体癌症免疫疗法的突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1197356752","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197356752?lang=zh_cn&edition=fundamental","pubTime":"2025-11-15 23:38","pubTimestamp":1763221107,"startTime":"0","endTime":"0","summary":"Lunai Bioworks在临床前人源化模型中实现原发性和转移性胰腺肿瘤的完全消退，标志着异体癌症免疫疗法的突破","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LNAI"],"gpt_icon":0},{"id":"2583507637","title":"Lunai Bioworks Inc.盘中异动 早盘股价大跌5.83%报0.970美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583507637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583507637?lang=zh_cn&edition=fundamental","pubTime":"2025-11-14 22:43","pubTimestamp":1763131397,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日22时43分，Lunai Bioworks Inc.股票出现异动，股价快速下跌5.83%。截至发稿，该股报0.970美元/股，成交量3.6453万股，换手率0.16%，振幅8.74%。Lunai Bioworks Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Cidara Therapeutics, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Aspire Biopharma Holdings, Inc.涨幅较大，Aspire Biopharma Holdings, Inc.、Salarius Pharmaceuticals, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为748.98%、80.30%、45.24%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cypherpunk Technologies Inc.、60 Degrees Pharmaceuticals, Inc.，振幅分别为46.41%、28.97%、26.50%。Lunai Bioworks Inc.公司简介：Lunai Bioworks Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142243189504b557&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142243189504b557&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LNAI","RENB","BK4139"],"gpt_icon":0},{"id":"2581401047","title":"Lunai Bioworks实现同种异体癌症免疫疗法的重大突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2581401047","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581401047?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 07:56","pubTimestamp":1762473360,"startTime":"0","endTime":"0","summary":"Lunai Bioworks在临床前人源化模型中实现原发及转移性胰腺肿瘤完全消退，标志着同种异体癌症免疫疗法的重大突破 Lunai Bioworks宣布其第二代同种异体树突状细胞疗法平台研究成果已发表于《Vaccines》期刊。尽管该同种异体DC产品已在胰腺癌模型中得到验证，但其治疗潜力有望拓展至多种实体瘤。关于LunaiLunai Bioworks Inc.是一家由AI驱动的药物发现与生物防御公司，致力于开拓安全且负责任的生成式生物学技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4817230_ZH17230_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["RENB","LNAI","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}]}}